Operating Lease, Right-of-Use Asset of Lexaria Bioscience Corp. from 01 Sep 2019 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lexaria Bioscience Corp. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Sep 2019 to 31 Aug 2025.
  • Lexaria Bioscience Corp. Operating Lease, Right-of-Use Asset for the quarter ending 31 Aug 2025 was $134,843, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $134,843 -$32,603 -19% 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q2 2025 $156,748 +$13,432 +9.4% 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 $156,748 +$6,751 +4.5% 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q3 2024 $167,446 $0 0% 31 Aug 2024 10-K 28 Nov 2025 2025 FY
Q2 2024 $143,316 31 May 2024 10-Q 12 Jul 2024 2024 Q3
Q1 2024 $149,997 29 Feb 2024 10-Q 09 Apr 2024 2024 Q2
Q3 2023 $167,446 31 Aug 2023 10-Q 12 Jul 2024 2024 Q3
Q2 2022 $62,363 -$37,893 -38% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 $72,099 -$37,207 -34% 28 Feb 2022 10-Q 11 Apr 2022 2022 Q2
Q4 2021 $81,656 -$36,537 -31% 30 Nov 2021 10-Q 14 Jan 2022 2022 Q1
Q3 2021 $91,041 -$35,879 -28% 31 Aug 2021 10-Q 14 Jul 2022 2022 Q3
Q2 2021 $100,256 31 May 2021 10-Q 15 Jul 2021 2021 Q3
Q1 2021 $109,306 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 $118,193 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 $126,920 -$33,369 -21% 31 Aug 2020 10-Q 15 Jul 2021 2021 Q3
Q3 2019 $160,289 01 Sep 2019 10-K 29 Nov 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.